Company Filing History:
Years Active: 1997
Title: Motoyuki Shimonaka: Innovator in Tumor Cell Research
Introduction
Motoyuki Shimonaka is a notable inventor based in San Diego, CA. He has made significant contributions to the field of cancer research, particularly in understanding tumor cell behavior. His work has implications for developing new therapeutic strategies against cancer.
Latest Patents
Motoyuki Shimonaka holds a patent for Epitaxin, a cell motility factor. This invention provides a substantially purified polypeptide, epitaxin, which is produced by fibroblasts and can stimulate migration of and DNA synthesis in tumor cells. The patent also includes antibodies that are specifically reactive with epitaxin and cell lines that produce such antibodies. Additionally, it offers an active fragment antagonist of ETX activity, which can reduce or inhibit at least one activity of ETX. The invention further outlines methods for controlling tumor cell migration and DNA synthesis, as well as increasing the sensitivity of tumor cells to cancer therapeutic agents.
Career Highlights
Motoyuki Shimonaka is associated with the La Jolla Cancer Research Foundation, where he continues to advance his research in cancer biology. His work has been instrumental in exploring the mechanisms of tumor cell migration and proliferation.
Collaborations
Motoyuki has collaborated with Yu Yamaguchi, contributing to the advancement of cancer research through their combined expertise.
Conclusion
Motoyuki Shimonaka's innovative work in the field of cancer research, particularly through his patent on Epitaxin, showcases his commitment to improving therapeutic strategies for tumor treatment. His contributions are vital in the ongoing battle against cancer.